FORMULATION AND PREPARATION OF ORALLY DISINTEGRATING TABLETS USING INNOVATIVE BINDER

被引:0
|
作者
Popa, Gratiela [1 ]
Ochiuz, Lacramioara [1 ]
Stoleriu, Iulian [2 ]
Cojocaru, Ileana [1 ]
Popovici, Iuliana [1 ]
机构
[1] Univ Med & Pharm Gr T Popa, Fac Pharm, Iasi 700115, Romania
[2] Alexandru Ioan Cuza Univ, Fac Math, Iasi 700506, Romania
关键词
Precirol ATO 5; orally disintegrating tablets; acetaminophen; RELEASE;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The present study investigates the use of glyceryl palmitostearate (Precirol ATO 5 - coded PATO) as binder in orally disintegrating tablets (ODT), prepared by melt granulation. PATO has been mentioned in literature for its lipophilic nature and fine powder properties, providing excelent coating and slow release of active drugs, but it can also be used for taste masking purposes, with possible applications in ODT. In order to use it as an ODT excipient, some challenges must be overcome, given its lipophilicity. Our first goal was to study its potential to improve tablet properties (hardness, friability, disintegration time) and provide fast release of the model drug, by setting the optimal proportion to be used in ODT. We investigated a complete 33 experimental design with 9 formulations containing 300 mg acetaminophen; the independent variables were: proportion of PATO binder (2.5-7.5 %) and proportion of sodium starch glycolate (Explotab) as superdisintegrant (5-10 %). The regression equations and response surface plots showed the validity of the model, and a significant influence of PATO on the response variables: tablet hardness, disintegration time, and active drug release in a short time. We can conclude that Precirol ATO 5 can be used as binder in ODT (not more than 5 %), higher proportions having a slow-release effect. Also, together with 8 % disintegrant, it provides good tablet properties, fast disintegration and a release of 80 % acetaminophen after 10 min.
引用
收藏
页码:1131 / 1136
页数:6
相关论文
共 50 条
  • [21] A new formulation for orally disintegrating tablets using a suspension spray-coating method
    Okuda, Y.
    Irisawa, Y.
    Okimoto, K.
    Osawa, T.
    Yamashita, S.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2009, 382 (1-2) : 80 - 87
  • [22] Recent Formulation Advances and Therapeutic Usefulness of Orally Disintegrating Tablets (ODTs)
    Chinwala, Maimoona
    [J]. PHARMACY, 2020, 8 (04)
  • [23] Formulation and evaluation of clozapine orally disintegrating tablets prepared by direct compression
    Olmez, S. S.
    Vural, I.
    Sahin, S.
    Ertugrul, A.
    Capan, Y.
    [J]. PHARMAZIE, 2013, 68 (02): : 110 - 116
  • [24] Application of polyvinyl alcohol in an innovative formulation strategy for lyophilized orally disintegrating tablets (vol 588, 119717, 2020)
    Vanbillemont, Brecht
    De Beer, Thomas
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2022, 624
  • [25] BINDER AND SUPERDISINTEGRANT INFLUENCE ON THE PROPERTIES OF ORALLY DISINTEGRATING HIGH DOSES ACETAMINOPHEN TABLETS
    Popa, Gratiela
    Ochiuz, Lacramioara
    Stoleriu, Iulian
    Popovici, Iuliana
    [J]. FARMACIA, 2010, 58 (03) : 303 - 307
  • [26] Formulation and evaluation of fexofenadine hydrochloride orally disintegrating tablets for pediatric use
    Turkmen, Omer
    Senyigit, Zeynep Ay
    Baloglu, Esra
    [J]. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2018, 43 : 201 - 210
  • [27] Efficacy, safety, and palatability of RACTAB ® formulation amlodipine orally disintegrating tablets
    Fukui-Soubou M.
    Terashima H.
    Kawashima K.
    Utsunomiya O.
    Terada T.
    [J]. Drugs in R & D, 2011, 11 (4) : 327 - 336
  • [28] PREPARATION AND CHARACTERIZATION OF ATENOLOL-β-CYCLODEXTRIN ORALLY DISINTEGRATING TABLETS
    Rani, Karina Citra
    Parfati, Nani
    Stephanie
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2020, 11 (01): : 68 - 79
  • [29] Orally Disintegrating Tablets: A Review
    Hirani, Jaysukh J.
    Rathod, Dhaval A.
    Vadalia, Kantilal R.
    [J]. TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2009, 8 (02) : 161 - 172
  • [30] Orally disintegrating tablets and orally disintegrating mini tablets - novel dosage forms for pediatric use
    Comoglu, Tansel
    Ozyilmaz, Emine Dilek
    [J]. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2019, 24 (07) : 902 - 914